Sign In

Eric Schaeffer

Independent Consultant at Schaeffer Biopharma Consulting

Professional Background

Eric Schaeffer is a highly esteemed professional in the pharmaceutical research and development sector, bringing over 30 years of extensive experience, particularly in the realms of neurodegenerative and neuropsychiatric diseases. His impressive career trajectory showcases an adeptness at managing diverse neuroscience portfolios and leading both large- and small-scale research and development teams that have successfully transitioned numerous drug candidates into clinical trials.

Eric's career is marked by a series of impactful roles in renowned organizations, demonstrating his versatility and significant contributions to neuroscience. He has held prominent positions such as Chief Scientific Officer at Paros Bio, where he directed innovative research initiatives, and Neuroscience Therapeutic Area Lead at Johnson & Johnson Innovation, where he was instrumental in advancing therapeutic solutions within a collaborative environment. Eric’s skillset extends beyond research and development, as he has also been at the forefront of strategic partnering, in-licensing, investment decisions, and fund raising, illustrating his comprehensive understanding of the pharmaceutical landscape.

In addition to his industry roles, Eric has leveraged his extensive expertise as an Independent Consultant through his firm, Schaeffer Biopharma Consulting, LLC. In this capacity, he has provided advisory services to various stakeholders, enhancing their capabilities in neuroscience ventures and drug development.

Education and Achievements

Eric's educational foundation is as robust as his professional endeavors. He completed his Ph.D. in Molecular Biology and Virology at the prestigious Albert Einstein College of Medicine, where he laid the groundwork for his in-depth understanding of biological processes. Postdoctoral fellowships at the notable laboratories of Paul Greengard at The Rockefeller University, a 2000 Nobel Laureate recognized for his groundbreaking work on synaptic transmission, and William Quinn at the Massachusetts Institute of Technology, specializing in learning and memory, further honed his research capabilities. His academic journey began with a BA in Biology from Colgate University, providing him with a comprehensive introduction to the life sciences.

Throughout his career, Eric has exhibited a multitude of achievements, particularly in critical evaluation of scientific data and effective communication—skills essential for successful collaboration across multidisciplinary teams. His ability to develop and implement cutting-edge research strategies has not only propelled forward innovative neuroscience initiatives but has also made impactful contributions to human health.

Notable Achievements

  • Leadership in Pharmaceutical Innovation: Eric has been a pivotal figure in facilitating strategic partnerships and spearheading clinical programs that focus on addressing complex neurodegenerative conditions. His leadership roles include being the Senior Director for Neuroscience Research at Pfizer and the Director of Neuropharmacology at CHDI Foundation, where he played a crucial part in deciphering the complexities of brain disorders and working towards innovative treatment methodologies.
  • Mentorship and Influence: Beyond his direct contributions to research, Eric has significantly influenced the next generation of scientists and researchers. His roles as an Independent Review Committee Member at Target ALS underscore his commitment to advancing knowledge and supporting scientific inquiry in neurodegeneration.
  • Cross-functional Team Leadership: His experience leading cross-functional teams has been instrumental in fostering a collaborative environment that promotes innovation. At Johnson & Johnson, he held the position of Senior Director, Neuroscience Innovation, where he effectively bridged gaps between various functions to streamline the drug development process, facilitating faster and more efficient pathways for therapeutic breakthroughs.
  • Consulting and Advisory Roles: As an independent consultant, Eric has utilized his wealth of knowledge to guide numerous organizations in the life sciences sector. His firm, Schaeffer Biopharma Consulting, LLC, offers tailored insights and actionable strategies that enhance the capabilities of clients looking to navigate the ever-evolving landscape of pharmaceutical development.

In summary, Eric Schaeffer exemplifies a well-rounded leader and innovator in pharmaceutical research and development, with a special focus on neurology. His combination of deep academic knowledge and vast industry experience positions him as a key contributor in the pursuit of novel therapeutics aimed at alleviating the burdens of neurodegenerative and neuropsychiatric diseases. Eric’s dedication to scientific advancement is clearly reflected in his professional journey and the positive impact he continues to make in the field.

Achievements

Expert in neuroscience drug development

Pharmaceutical consulting

Innovative research strategies

Clinical trial administration

Cross-functional team leader

Neurodegenerative disease expertise

Strategic partnership leadership

Fund raising for biotech

Evaluating scientific data

Related Questions

How did Eric Schaeffer's postdoctoral experiences shape his approach to scientific research?
What strategies has Eric Schaeffer employed to successfully lead cross-functional teams in drug development?
How does Eric Schaeffer evaluate scientific data for drug candidates in the pharmaceutical industry?
What are Eric Schaeffer's views on the future of neurodegenerative disease treatments?
In what ways has Eric Schaeffer contributed to strategic partnerships in the biotechnology sector?
What led Eric Schaeffer to transition from industry roles to consulting?
How has Eric Schaeffer's education influenced his career trajectory in neuroscience?
Eric Schaeffer
Add to my network

Location

New York, New York, United States